Pillai Pallavi Madhusoodhan, MD Email Pillai Pallavi Madhusoodhan
- ASSISTANT PROFESSOR | Pediatrics, Hematology/Oncology
- Pediatric Hematology-Oncology
- Hospital Affiliations
- The Mount Sinai Hospital
- Mount Sinai Morningside and Mount Sinai West
- Mount Sinai Beth Israel
- Pediatric Hematology-Oncology 212-241-7022 212-241-7022
P. Pallavi Madhusoodhan, MD, is an Assistant Professor in the Jack Martin Division of Pediatric Hematology-Oncology at the Mount Sinai Kravis Children's Hospital's Children's Cancer Program in the Jack and Lucy Clark Department of Pediatrics at the Icahn School of Medicine at Mount Sinai. She completed her medical schooling in India and underwent pediatric training at the Royal College of Pediatrics and Child Health in London, United Kingdom. In the United States, she did her Pediatric Residency training at The Brooklyn Hospital Center and went on to a Pediatric Hematology Oncology Fellowship at The New York University School of Medicine. She was Division Director of Pediatric Hematology-Oncology and Director of the Pediatric Comprehensive Sickle cell program at The Brooklyn Hospital Center prior to joining Mount Sinai. She is Board Certified in Pediatrics and in Pediatric Hematology-Oncology.
Her primary clinical focus is in Pediatric Hematology, both benign and malignant. She is actively involved in basic and translational research projects looking at mechanisms of chemotherapy resistance in relapsed pediatric B-lymphoblastic leukemia. Her research has been recognized and funded by awards like the American Society of Hematology Research and Training Award for Fellows (ASH-RTAF), the Children’s Oncology Group Hematologic Malignancies Translational Pilot Studies Program Grant (COG-HMTPSP) and the American Society of Pediatric Hematology Oncology Early Career award. She has a keen interest in clinical research in benign hematology, specifically sickle cell disease in children and the importance of a comprehensive multidisciplinary approach to its long term management. She is working on building collaborations to enable patients with sickle cell disease gain access to the latest clinical trials and novel therapeutics in the field.
Pediatric Hematology & Oncology
American Board of Pediatrics
- Bleeding Disorders
- Coagulation Disorders
- Hematologic Malignancies, Pediatric
- Pediatric Leukemia/Lymphoma
- Sickle Cell Disease/Sickle Cell Anemia
- Thalassemia Major And Minor
MBBS, Rural Medical College
The Brooklyn Hospital Center
Fellowship, Pediatric Hematology/Oncology
New York University School of Medicine
Children’s Oncology Group Hematologic Malignancies Translational Pilot Studies Program Grant (COG-HMTPSP)
American Society of Pediatric Hematology-Oncology (ASPHO) Early Career Travel Award
American Society of Hematology Research and Training Award for Fellows (ASH-RTAF)
Vincent Tricomi, M.D Resident Research Award
The Brooklyn Hospital Centre
The Brooklyn Pediatric Society Resident Research Award
Best Resident Teacher Award
The Brooklyn Hospital Centre
AAP Program Delegate Award to the AAP NCE
AAP Allergy-immunology Travel Grant Recipient to the AAP NCE
Role of the Mitogen Activated Protein Kinase (MAPK) pathway in relapsed pediatric B-Lymphoblastic leukemia: Prognostic and therapeutic implications.
MSH6 Haploinsufficiency at Relapse Contributes to the Development of Thiopurine Resistance in Pediatric B-Lymphoblastic Leukemia.
An Assessment of disease knowledge differences between adolescents with sickle cell disease and their parents and its correlation to quality of life.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Madhusoodhan did not report having any of the following types of financial relationships with industry during 2019 and/or 2020: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.